Sinopia Biosciences
Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
About
Technology stack
detected 2026-06-17
SquarespaceNo comments yet. Be the first to share your take.
What does Sinopia Biosciences do?
Sinopia Biosciences is a biotechnology company focused on developing novel therapeutics. They leverage their proprietary LEADS® (LEarn And DiScover) drug discovery platform, which utilizes metabolomics-driven discovery capabilities. The company has received a research grant from the National Cancer Institute (NCI) to expand the application of its platform to oncology.
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised a total of $2M in funding. The most recent round on record is Grant.
Where is Sinopia Biosciences headquartered?
Sinopia Biosciences is headquartered in San Diego, California, USA.
When was Sinopia Biosciences founded?
Sinopia Biosciences was founded in 2017.
What industry does Sinopia Biosciences operate in?
Sinopia Biosciences operates in Biotechnology, Drug Discovery, Oncology, Biotech, AI Drug Discovery, Metabolomics.